Skip to main content
. 2019 Oct 15;10(57):5894–5905. doi: 10.18632/oncotarget.27185

Figure 3. Dose-response effect of PEDF on SKOV3 cell viability in the presence and absence of Paclitaxel.

Figure 3

(A) Dose-response effect of recombinant PEDF (rPEDF) on SKOV3 cell viability. The 50% inhibitory concentration (IC50) of recombinant PEDF was calculated using Compusyn software.(B) Determination of the minimal rPEDF concentration allowing additional effect with paclitaxel (Ptx at 100 nM, for 48h) on SKOV3 cell viability.